cdmo.directory
← Compare landing

Charles River Cell & Gene Therapy vs Lonza Cell & Gene Technologies

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/criver/lonza

CategoryCharles River Cell & Gene TherapyLonza Cell & Gene Technologies
Listed sitecdmocdmo
SummaryCharles River provides discovery, development, and manufacturing services across the drug development continuum, including cell and gene therapy capabilities.Lonza is the world's leading CDMO, founded in Switzerland in 1897, serving the healthcare industry with integrated offerings for contract development and manufacturing of therapies across multiple modalities.
Services
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • Technology Transfer
  • Formulation Development
  • Process Development
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Biologics Development & Manufacturing
  • API Synthesis & Manufacturing
  • Upstream Processing
  • Downstream Processing
  • CMC Analytical Development
  • Stability Testing & Storage
  • Cell-Line Development
  • Microbial Fermentation
  • Small Molecule Development & Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Cell-Line Development
  • Protein Engineering
  • Analytical Method Development & Validation
  • Process Development
  • Formulation Development
  • Technology Transfer
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Biologics Development & Manufacturing
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Regulatory Affairs
  • Cell Therapy Manufacturing
  • Upstream Processing
  • Downstream Processing
  • Quality Control Testing
  • Microbiology Services
  • Translational Research
  • CMC Analytical Development
  • Stability Testing & Storage
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
Indications
  • Oncology
  • Immunology
  • Neurology
Data not yet provided.
Locations
  • Headquarters, United States
  • North America, North America
  • Europe, Europe
  • Asia, Asia
  • Headquarters, Basel, Basel-Stadt, Switzerland
Certifications
  • FDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • PMDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: Retrogenix® platform data support
  • PMDA · Identifier: Retrogenix® platform data support
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.